Physician profile
Stephen Daniel Lynch
NPI 1396128187
$19,984.75
in general payments reported to CMS, 2019-2025
34 companies · $2,695 in 2025
The $2,695 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,971 · 2020: $556 · 2021: $429 · 2022: $5,529 · 2023: $5,116 · 2024: $3,689 · 2025: $2,695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,593 · Travel and Lodging: $1,982 · Consulting Fee: $1,800 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,592.97 |
| Travel and Lodging | $1,982.05 |
| Consulting Fee | $1,800.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Circulation INC | $6,910.56 | 2022-2024 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Amgen INC. | $1,906.12 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $1,410.08 | 2019-2025 | Amplatzer Amulet, Cardiomems, Perclose Proglide |
| Edwards Lifesciences Corporation | $1,409.88 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Ancora Heart, INC. | $1,201.36 | 2023-2024 | Accucinch |
| Inari Medical, INC. | $1,068.70 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $836.19 | 2019-2025 | |
| Boston Scientific Corporation | $630.28 | 2019-2025 | Avvigo Guidance System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $536.40 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $449.43 | 2019-2025 | |
| Cathworks, INC. | $436.87 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $354.71 | 2023-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $324.08 | 2019-2020 | |
| Stryker Corporation | $290.08 | 2025 | Clottriever Bold Catheter, Flowtriever, Flowtriever Catheter, S |
| Penumbra, INC. | $277.00 | 2022-2024 | Penumbra System |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inquis Medical, INC. | $269.68 | 2024-2025 | Aventus |
| Philips North America LLC | $232.42 | 2023-2025 | IV Other |
| Astellas Pharma US INC | $198.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $197.70 | 2019-2023 | Xarelto |
| Kestra Medical Technology Services, INC. | $153.65 | 2025 | Assure Wcd |
| Shockwave Medical, INC | $152.80 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Genzyme Corporation | $149.99 | 2022 | |
| Chiesi USA, INC. | $136.47 | 2024-2025 | Cleviprex, Kengreal |
| Medtronic, INC. | $113.68 | 2024-2025 | In.Pact Admiral, Symplicity G3, V-Loc 180 |
| Novo Nordisk INC | $104.67 | 2022 | |
| Pfizer INC. | $56.20 | 2024-2025 | |
| Teleflex LLC | $35.55 | 2020-2023 | Manta |
| Impulse Dynamics (USA) INC. | $30.87 | 2023 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.21 | 2025 | Jardiance |
| Merck Sharp & Dohme LLC | $20.52 | 2025 | Verquvo |
| Alnylam Pharmaceuticals INC. | $20.23 | 2025 | Onpattro |
| Cardiovascular Systems INC. | $15.54 | 2021 | |
| Janssen Scientific Affairs, LLC | $13.77 | 2024 | Xarelto |
| Siemens Medical Solutions USA, INC. | $13.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$220.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.